The drug erenumab has been shown to reduce the frequency of migraines and improve migraine patients’ quality of life in studies that have lasted between 3 and 12 months. However, there has thus far been little research on the long-term effects of this particular therapeutic strategy. Treating migraine is known to be a complex challenge, and people … [Read more...]
Migraine Drug Shown for First Time to Provide Long-Term Benefits to Patients
How is Artificial Intelligence Helping with Emergency Medicine?
Artificial intelligence has had a tremendous impact in medicine, with applications in areas spanning administrative tasks and clinical medicine. The specific value that artificial intelligence brings to medicine brings varies based on several factors including the task at hand and the medical specialty involved. It has, for instance, been … [Read more...]
Healthcare Workers at Increased Risk for Voice Disorders During Pandemic
A new study published in Laryngoscope has tackled the issue of whether healthcare workers who have been caring for patients in high-risk units during the COVID-19 outbreak are at increased risk for voice disorders. This cross-sectional study involved a questionnaire that more than 220 healthcare workers answered. The questionnaire included … [Read more...]
New Data on Environmental Factors that May Contribute to ALS
Amyotrophic lateral sclerosis (ALS) is most often classified as sporadic. Because there is no known genetic explanation for the majority of cases of ALS, physicians, and other healthcare experts have long investigated the potential environmental influences that may lead to the development of this devastating degenerative disorder. The authors of … [Read more...]
Preoperative Paracetamol Appears Ineffective in Reducing Pain From Dental Surgeries
Minimizing pain associated with surgeries has been of clinical and research interest for centuries. A new study has investigated the potential to reduce surgical pain in children following dental treatments using paracetamol before the procedure. Researchers compared the effects of paracetamol and placebo in children between the ages of 5 and 12 … [Read more...]